A Dose Finding, Efficacy and Safety Study of Ensovibep (MP0420) in Ambulatory Adult Patients With Symptomatic COVID-19
Clinical trial NCT04828161 · TERMINATED
Trial details
- NCT number
- NCT04828161
- Sponsor
- Novartis Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-05-10
- Primary completion
- 2021-11-18
- Enrollment
- 407
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.